EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus

Aleksi Vanninen, Heikki Lukkarinen, Tarja Kokkola, Anne M Koivisto, Merja Kokki, Tadeusz Musialowicz, Mikko Hiltunen, Henrik Zetterberg, Ville Leinonen, Sanna-Kaisa Herukka, Tuomas Rauramaa

Journal of Alzheimer's Disease · 18.07.2023 · 94 (2) · 727-736

DOI: 10.3233/jad-230144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 18.07.2023. Verfasst von Aleksi Vanninen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland. Hauptthemen laut MEDLINE: Alzheimer Disease, Hydrocephalus, Normal Pressure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer’s disease (AD) is the most common cause of dementia worldwide and a frequent comorbidity in idiopathic normal pressure hydrocephalus (iNPH). The presence of AD pathology is associated with worse outcomes after a shunt procedure in iNPH. Preoperative diagnosis of AD is challenging in patients with iNPH, which involves reduced concentrations of the cerebrospinal fluid (CSF) AD biomarkers.

Objective

Our aim was to estimate the effect size of iNPH as a factor in CSF levels of AD biomarkers and to test if correction could be used to improve diagnostic value.

Methods

Our cohort included 222 iNPH patients with data in the Kuopio NPH registry and brain biopsy and CSF samples available. We divided the patients into groups according to AD pathology per brain biopsy. For control cohorts, we had CSF samples from cognitively healthy individuals (n = 33) and patients with diagnosed AD and no iNPH (n = 39). *-31pt Results: Levels of all investigated biomarkers differed significantly between groups, with the exception of t-Tau levels between healthy individuals and iNPH patients with AD pathology. Applying a correction factor for each biomarker (0.842*Aβ1 - 42, 0.779*t-Tau, and 0.610*P-Tau181) for the effect of iNPH yielded a sensitivity of 2.4% and specificity of 100%. The ratio of P-Tau181 to Aβ1 - 42 was moderately effective in aiding recognition of AD pathology in iNPH patients (sensitivity 0.79, specificity 0.76, area under the curve 0.824).

Conclusion

Correcting for iNPH as a factor failed to improve diagnostic effectiveness, but the P-Tau181/Aβ1 - 42 ratio showed some utility in the diagnosis of AD in iNPH patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHydrocephalus, Normal PressureHumansAmyloid beta-Peptidestau ProteinsBiomarkers

Stichwörter der Autor:innen

Alzheimer’s diseasebraincerebrospinal fluidneedle biopsynormal pressure hydrocephalus

Substanzen

Amyloid beta-Peptidestau ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland.
  • Neurosurgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Department of Neurology, Kuopio University Hospital, Kuopio, Finland.
  • Department of Neurosciences, University of Helsinki, Helsinki, Finland.
  • Department of Geriatrics, Helsinki University Hospital, Helsinki, Finland.

Zitieren

APA

Vanninen, A., Lukkarinen, H., Kokkola, T., Koivisto, A. M., Kokki, M., Musialowicz, T., Hiltunen, M., Zetterberg, H., Leinonen, V., Herukka, S. K., & Rauramaa, T. (2023). Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer's Disease, 94(2), 727-736. https://doi.org/10.3233/jad-230144

Vancouver

Vanninen A, Lukkarinen H, Kokkola T, Koivisto AM, Kokki M, Musialowicz T, et al. Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer's Disease. 2023;94(2):727-736. doi:10.3233/jad-230144

BibTeX
@article{Vanninen2023,
  author = {Vanninen, Aleksi and Lukkarinen, Heikki and Kokkola, Tarja and Koivisto, Anne M and Kokki, Merja and Musialowicz, Tadeusz and Hiltunen, Mikko and Zetterberg, Henrik and Leinonen, Ville and Herukka, Sanna-Kaisa and Rauramaa, Tuomas},
  title = {Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  volume = {94},
  number = {2},
  pages = {727--736},
  doi = {10.3233/jad-230144}
}
Kostenlos starten →